The Mechanism of the Low Molecular Dextran in Microvascular Surgery

安智全,顾玉东,钟高仁,朱建华,徐明光,许小凤,高福琴
DOI: https://doi.org/10.3760/cma.j.issn.1005-054x.2002.03.022
2002-01-01
Abstract:Objective To assess the effects of dextran on the function of coagulative system and the platelet deposition at the anastomotic sites. Methods 32 SD rat were randomly divided into the experimental (24) and the control (8) groups. Dextran 40 (8.5 ml/kg) was administered through a catheter placed in a femoral vein at experimental group and the same volume of 5% Glucose solution at control group. Blood samples were taken and the platelet aggregation, PT and KPTT were tested. 16 New Zealand White rabbits were divided into experimental and control groups, with 8 in each. The bilateral femoral arteries were transected and anastomosed in an end to end way. 30 minutes before surgery, dextrans 40 was given via ear marginal vein (8.5ml/kg).15 and 120 minutes after the re establishment of blood flow, the bilateral anastomotic sites were given with 125 I labeled anti GPⅡb/Ⅲa antibody(SZ 21). Then the radioactivities were measured. Results Compared with the control group, the maximal aggregation rates of platelet in experimental groups decreased 43.44%(on average) at postoperative 1,3,6 and 12 hours. KPTT was longer in experimental group than that in the control group at postoperative 1,3,6 hours, with 74.31% longer at 1h point(on average). 15 and 120 minutes after the re establishment, all of the artery were patent. The radioactivities at the anastomotic site in experimental groups increased 121.80% and 47.82% when compared with the control group.Conclusions The low molecular dextran can inhibit the platelet aggregation and intrinsic coagulation system, but it has no significant influence on the platelet deposition at the anastomotic sites.
What problem does this paper attempt to address?